find the latest legal job
Corporate/Commercial Lawyers (2-5 years PAE)
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Specialist commercial law firm · Long-term career progression
View details
Graduate Lawyer / Up to 1.5 yr PAE Lawyer
Category: Personal Injury Law | Location: Brisbane CBD & Inner Suburbs Brisbane QLD
· Mentoring Opportunity in Regional QLD · Personal Injury Law
View details
Corporate and Commercial Partner
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Full time · Join a leading Adelaide commercial law firm
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Sydney NSW
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Melbourne VIC
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
Failed Vioxx action hits Slaters’ profit

Failed Vioxx action hits Slaters’ profit

Slater & Gordon’s failed class action against the maker of anti-arthritis drug Vioxx was the main factor leading to a 10.5 per cent profit drop for the law firm.

Slaters, one of Australia’s two listed law firms, saw its profit after tax (NPAT) drop to $25 million in the year to June 30; down from $27.9 million in the previous year.

Slaters’ managing director Andrew Grech (pictured) told Lawyers Weekly the Vioxx class action fail hit the company hard but that the financial results came as no surprise to analysts or Slaters’ investors.

“While it was very disappointing, I think the important thing to emphasis is it’s very much a once-off situation and certainly not indicative of what’s in the portfolio of cases we have in the future, most of which, in the class action area, are funded by third party litigation funders now,” he said.

The failed class action against the Australian subsidiary of global drug company Merck Sharp & Dohme saw a $10.5 million earnings loss.

Slaters funded the class action, which sought damages for people who suffered heart attacks after taking the non-steroid, anti-inflammatory drug Vioxx.

The case was lost on appeal in the Full Federal Court in October 2011 and the High Court declined to grant leave to appeal the decision in May.

However, the firm’s normalised profits, which snub out the Vioxx non-cash write-down, rose 15.5 per cent to $33.4 million.

Total revenue was up 19.4 per cent on the previous year to $218 million, with the recently acquired UK firm Russell Jones & Walker adding $12 million to Slaters’ revenue result in the first two months since operation.

Cash flow from operations represented half of the total NPAT for the Australian operations before the Vioxx write-down. This was below the company’s guidance range for the year of 65 to 70 per cent due to billing being weighted to June 2012 more strongly than expected.

Grech said he expected revenue to grow to $290 million in 2012-13.

“The potential to exploit the Slater & Gordon brand in markets outside personal injuries is still largely untapped,” he said, adding that the firm would look to do work for people who fit within its existing client demographic.

“State ligation, wills, succession planning, wealth protection; all of the areas that are in that sort of rubric … the sorts of legal services that everyday people require through their lives and a few add-ons. For example, we’ve just started developing a criminal defence practice for people with traffic offences and the like.”

When asked for any further comment on allegations over Julia Gillard's departure from Slaters and the firm’s 1995 internal probe into her work, Grech said: “More than enough ink has been spilt on the topic”.

Gillard fronted a marathon press conference last Thursday (August 23) after The Australian issued a three-line apology over allegations it published claiming the Prime Minister had helped set up a union ‘slush’ fund while working as a lawyer 17 years ago.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Failed Vioxx action hits Slaters’ profit
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
Scales of Justice
Dec 15 2017
Timing ‘critical’ in unusual contempt of court ruling
A recent case could have interesting implications for contempt of court rulings, according to a Ferr...
Dec 14 2017
International arbitration and business culture
Promoted by Maxwell Chambers. This article discusses the impact of international arbitration on t...
Papua New Guinea flag
Dec 14 2017
World-first mining case launched in PNG
Citizens of Papua New Guinea have launched landmark legal proceedings against the country’s govern...
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...